![]() |
市場調査レポート
商品コード
1619035
遺伝子編集の世界市場規模、シェア、成長分析:技術別、提供別、用途別、エンドユーザー別、地域別 - 産業予測(2024年~2031年)Gene Editing Market Size, Share, Growth Analysis, By Type, By Application, By Region - Industry Forecast 2024-2031 |
||||||
|
遺伝子編集の世界市場規模、シェア、成長分析:技術別、提供別、用途別、エンドユーザー別、地域別 - 産業予測(2024年~2031年) |
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
世界の遺伝子編集の市場規模は、2022年に54億米ドルと評価され、2023年の62億4,000万米ドルから2031年には197億5,000万米ドルに成長し、予測期間中(2024年~2031年)のCAGRは15.5%で成長する見通しです。
世界の遺伝子編集市場は、特にCRISPR-Cas9やTALENのような技術を通じたバイオテクノロジーの進歩により、著しい成長を遂げています。個別化医療の需要と研究開発投資の増加は、遺伝子疾患やがんの治療用途の拡大とともに、この市場の主要促進要因となっています。農業分野でも、作物の収量や病気への耐性を高めるために遺伝子編集が採用されています。製薬会社やバイオテクノロジー会社を含む大手企業は、激しい競争の中で研究能力を拡大するために戦略的提携を行っています。北米は先進的なヘルスケアシステムに支えられて市場をリードしており、アジア太平洋はヘルスケア支出の増加と政府支援に後押しされて大きく成長しようとしています。倫理的・規制的課題にもかかわらず、市場は今後数年で大きく成長すると予想されます。
Global Gene Editing Market size was valued at USD 5.40 billion in 2022 and is poised to grow from USD 6.24 billion in 2023 to USD 19.75 billion by 2031, growing at a CAGR of 15.5% during the forecast period (2024-2031).
The Global Gene Editing Market has seen remarkable growth due to advancements in biotechnology, particularly through technologies like CRISPR-Cas9 and TALENs. The demand for personalized medicine and increased investments in R&D are key drivers of this market, alongside the expanding therapeutic applications for genetic disorders and cancers. The agriculture sector is also embracing gene editing to enhance crop yield and resistance to diseases. Major players, including pharmaceutical and biotechnology companies, are engaged in strategic collaborations to broaden their research capabilities amid intense competition. North America leads the market, backed by advanced healthcare systems, while Asia-Pacific is poised for significant growth fueled by rising healthcare spending and governmental support. Despite ethical and regulatory challenges, the market is expected to grow substantially in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Editing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Gene Editing Market Segmental Analysis
Global Gene Editing Market is segmented by technology, offerings, application, end user and region. Based on technology, the market is segmented into CRISPR, TALENs, zinc finger nucleases (ZFNs), restriction enzymes and others. Based on offerings, the market is segmented into products and services. Based on application, the market is segmented into genetic engineering, clinical applications, drug discovery and development and agriculture. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Gene Editing Market
A major factor propelling the global gene editing market is the rising demand for personalized medicine. Gene editing technologies provide opportunities to craft bespoke therapies and treatments, specifically designed around an individual's unique genetic profile. This customized approach not only promises better treatment effectiveness and fewer side effects but also aims to enhance overall patient health. As awareness of personalized medicine grows, so too does the push for targeted therapies, significantly driving the adoption and progression of gene editing innovations. Consequently, the drive for personalized healthcare solutions is a crucial catalyst in the evolution of the gene editing landscape.
Restraints in the Global Gene Editing Market
A significant restraint in the global gene editing market stems from ethical and regulatory challenges inherent to the technology. The manipulation of genetic material raises intricate ethical dilemmas, especially concerning germline editing and changes that can be passed to future generations. Ongoing debates surrounding the moral implications and potential long-term effects of gene editing further complicate its acceptance. Moreover, the regulatory landscapes governing gene editing practices differ widely across jurisdictions and are in a constant state of flux. The imperative for robust ethical guidelines and unambiguous regulatory frameworks presents a notable obstacle to the market's expansion and broader implementation.
Market Trends of the Global Gene Editing Market
The global gene editing market is increasingly centered on therapeutic applications, significantly driving growth in gene therapies. As advancements in technologies such as CRISPR and TALEN enable precise interventions at the genetic level, there is a heightened focus on addressing genetic disorders, cancers, and other complex diseases through targeted treatments. This shift is catalyzed by a surge in research initiatives and collaborations among biopharmaceutical companies, academic institutions, and healthcare organizations, aimed at unlocking the full potential of gene editing for innovative therapies. The burgeoning interest in personalized medicine underscores the transformative impact of gene editing on the future of healthcare, particularly in meeting unmet medical needs.